Rivaroxaban NOBEL 10 mg
Rivaroxaban NOBEL 10 mg is a medicine authorised by Swissmedic under authorisation number 68009. The authorisation holder is NOBEL Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 28 April 2022 and the authorisation is limited until 27 April 2027. ATC code B01AF01 places the medicine in the group Antithrombotic agents.
| Authorisation number | 68009 |
|---|---|
| Name | Rivaroxaban NOBEL 10 mg |
| Full name | Rivaroxaban NOBEL 10 mg, Filmtabletten |
| Authorisation holder | NOBEL Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B01AF01 |
| First authorisation | 28 April 2022 |
| Authorisation validity | 27 April 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rivaroxaban NOBEL 10 mg, Filmtabletten | B | 28 April 2022 |
| 2 | Rivaroxaban NOBEL 15 mg, Filmtabletten | B | 28 April 2022 |
| 3 | Rivaroxaban NOBEL 20 mg, Filmtabletten | B | 28 April 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 2 | 30 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 3 | 100 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 4 | 14 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 5 | 28 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 6 | 98 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 7 | 14 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 8 | 28 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 9 | 98 | Tablette(n) | B01AF01 | 06.03.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Rivaroxaban NOBEL 10 mg authorised in Switzerland?
Yes. Rivaroxaban NOBEL 10 mg is authorised by Swissmedic under authorisation number 68009, data as of 01 September 2026. The authorisation is limited until 27 April 2027.
Which dispensing category does Rivaroxaban NOBEL 10 mg have?
Rivaroxaban NOBEL 10 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Rivaroxaban NOBEL 10 mg?
The authorisation holder is NOBEL Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.